Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The Quarterly

Jan 08, 2007 07:57AM

Jan 08, 2007 09:32AM

Jan 08, 2007 09:42AM

I would consider a surprise in the quarterly to be a better than expected licensing fee paid by one of the signers - this is a long shot - and the market agrees judging from the current price action.

I also believe that "if" the J3 make us a great offer before the Markman, Patriot would settle before the Markman. This would also send a strong message to the industry IMO. (I also consider this a long shot.)


Jan 08, 2007 10:33AM

Jan 08, 2007 10:40AM

Jan 08, 2007 10:46AM

Jan 08, 2007 10:53AM

Jan 08, 2007 11:06AM

Jan 08, 2007 11:09AM

Jan 08, 2007 11:46AM

Jan 08, 2007 01:08PM

Jan 08, 2007 07:03PM
Share
New Message
Please login to post a reply